Once vs twice-daily abacavir and lamivudine in African children-Reference-Cited by-同舟云学术

Once vs twice-daily abacavir and lamivudine in African children

Published:2016-07-17 Issue:11 Volume:30 Page:1761-1770
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Musiime Victor,Kasirye Philip,Naidoo-James Bethany,Nahirya-Ntege Patricia,Mhute Tawanda,Cook Adrian,Mugarura Lincoln,Munjoma Marshall,Thoofer Navdeep K.,Ndashimye Emmanuel,Nankya Immaculate,Spyer Moira J.,Thomason Margaret J.,Snowden Wendy,Gibb Diana M.,Walker Ann Sarah

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference21 articles.

1. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes;Nachega;Ann Intern Med,2007

2. Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression;Boyle;HIV Clin Trials,2008

3. Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL30001 Study);Lamarca;J Acquir Immune Defic Syndr,2006

4. Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination Study;Moyle;J Acquir Immune Defic Syndr,2005

5. Abacavir and lamivudine fixed-dose combination tablet once daily compared with abacavir and lamivudine twice daily in HIV-infected patients over 48 weeks (ESS30008, SEAL);Sosa;J Acquir Immune Defic Syndr,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Model‐Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed‐Dose Combination Approval in Children Living with HIV‐1;The Journal of Clinical Pharmacology;2024-09-05

2. Children living with HIV: a narrative review of recent advances in pediatric HIV research and their implications for clinical practice;Therapeutic Advances in Infectious Disease;2022-01

3. The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa;AIDS;2021-04-14

4. Not yet 90-90-90: A quality improvement approach to human immunodeficiency virus viral suppression in paediatric patients in the rural Eastern Cape, South Africa;South African Family Practice;2020-10-15

5. Brief Report: Cessation of Long-Term Cotrimoxazole Prophylaxis in HIV-Infected Children Does Not Alter the Carriage of Antimicrobial Resistance Genes;JAIDS Journal of Acquired Immune Deficiency Syndromes;2020-08-25